Therapeutic hypothermia in deceased organ donors and kidney-graft function

New England Journal of Medicine

Volumn 373, Issue 5, 2015, Pages 405-414

  Niemann, Claus U ^a   Feiner, John ^a   Swain, Sharon ^b   Bunting, Scott ^c   Friedman, Melissa ^c   Crutchfield, Megan ^d   Broglio, Kristine ^f   Hirose, Ryutaro ^a   Roberts, John P ^a   Malinoski, Darren ^d,e  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b California Transplant Donor Network   (United States)

^c OneLegacy   (United States)

^d VETERANS AFFAIRS PORTLAND HEALTH CARE SYSTEM   (United States)

^e OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^f BERRY CONSULTANTS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BODY TEMPERATURE; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; DECEASED ORGAN DONOR; DELAYED GRAFT FUNCTION; EARLY TERMINATION OF CLINICAL TRIAL; FEMALE; GRAFT RECIPIENT; HUMAN; INDUCED HYPOTHERMIA; KIDNEY GRAFT; KIDNEY GRAFT FUNCTION; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MULTICENTER STUDY; ORGAN DONOR; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RENAL PROTECTION; RENAL REPLACEMENT THERAPY; BODY MASS; BRAIN DEATH; CADAVER; CLINICAL TRIAL; DONOR; KIDNEY; ORGAN PRESERVATION; PHYSIOLOGY; PROCEDURES;

ADULT; BODY MASS INDEX; BRAIN DEATH; CADAVER; FEMALE; HUMANS; HYPOTHERMIA, INDUCED; KIDNEY; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; ORGAN PRESERVATION; PROSPECTIVE STUDIES; TISSUE DONORS;

EID: 84938334830     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMoa1501969     Document Type: Article

References (22)

1. Mallon DH, Summers DM, Bradley JA, Pettigrew GJ. Defining delayed graft function after renal transplantation: simplest is best. Transplantation 2013;96:885-9.
2. McLaren AJ, Jassem W, Gray DW, Fuggle SV, Welsh KI, Morris PJ. Delayed graft function: risk factors and the relative effects of early function and acute rejection on long-term survival in cadaveric renal transplantation. Clin Transplant 1999;13:266-72.
3. Butala NM, Reese PP, Doshi MD, Parikh CR. Is delayed graft function causally associated with long-term outcomes after kidney transplantation? Instrumental variable analysis. Transplantation 2013;95:1008-14.
4. Tapiawala SN, Tinckam KJ, Cardella CJ, et al. Delayed graft function and the risk for death with a functioning graft. J Am Soc Nephrol 2010;21:153-61.
5. Yarlagadda SG, Coca SG, Formica RN Jr, Poggio ED, Parikh CR. Association between delayed graft function and allograft and patient survival: a systematic review and meta-analysis. Nephrol Dial Transplant 2009;24:1039-47.
6. Fonseca I, Teixeira L, Malheiro J, et al. The effect of delayed graft function on graft and patient survival in kidney transplantation: an approach using competing events analysis. Transpl Int 2015;28:738-50.
7. Irish WD, Ilsley JN, Schnitzler MA, Feng S, Brennan DC. A risk prediction model for delayed graft function in the current era of deceased donor renal transplantation. Am J Transplant 2010;10:2279-86.
8. Yarlagadda SG, Coca SG, Garg AX, et al. Marked variation in the definition and diagnosis of delayed graft function: a systematic review. Nephrol Dial Transplant2008;23:2995-3003.
9. Debaty G, Maignan M, Savary D, et al. Impact of intra-arrest therapeutic hypothermia in outcomes of prehospital cardiac arrest: a randomized controlled trial. Intensive Care Med 2014;40:1832-42.
10. Azzopardi D, Strohm B, Marlow N, et al. Effects of hypothermia for perinatal asphyxia on childhood outcomes. N Engl J Med 2014;371:140-9.
11. van der Worp HB, Macleod MR, Bath PMW, et al. EuroHYP-1: European multicenter, randomized, phase III clinical trial of therapeutic hypothermia plus best medical treatment vs. best medical treatment alone for acute ischemic stroke. Int J Stroke 2014;9:642-5.
12. Nielsen N, Wetterslev J, Cronberg T, et al. Targeted temperature management at 33°C versus 36°C after cardiac arrest. N Engl J Med 2013;369:2197-206.
13. Wolfrum S, Pierau C, Radke PW, Schunkert H, Kurowski V. Mild therapeutic hypothermia in patients after out-of-hospital cardiac arrest due to acute ST-segment elevation myocardial infarction undergoing immediate percutaneous coronary intervention. Crit Care Med 2008;36:1780-6.
14. Tissier R, Giraud S, Quellard N, et al. Kidney protection by hypothermic total liquid ventilation after cardiac arrest in rabbits. Anesthesiology 2014;120:861-9.
15. Polderman KH. Mechanisms of action, physiological effects, and complications of hypothermia. Crit Care Med 2009;37:Suppl:S186-S202.
16. National Science Foundation federal policy for the protection of human subjects. 2002 (http://www.nsf.gov/bfa/dias/policy/docs/45cfr690.pdf).
17. Patel MS, Zatarain J, De La Cruz S, et al. The impact of meeting donor management goals on the number of organs transplanted per expanded criteria donor: a prospective study from the UNOS Region 5 Donor Management Goals Workgroup. JAMA Surg 2014;149:969-75.
18. Port FK, Bragg-Gresham JL, Metzger RA, et al. Donor characteristics associated with reduced graft survival: an approach to expanding the pool of kidney donors. Transplantation 2002;74:1281-6.
19. Israni AK, Salkowski N, Gustafson S, et al. New national allocation policy for deceased donor kidneys in the United States and possible effect on patient outcomes. J Am Soc Nephrol 2014;25:1842-8.
20. Schnuelle P, Gottmann U, Hoeger S, et al. Effects of donor pretreatment with dopamine on graft function after kidney transplantation: a randomized controlled trial. JAMA 2009;302:1067-75.
21. Abt PL, Marsh CL, Dunn TB, et al. Challenges to research and innovation to optimize deceased donor organ quality and quantity. Am J Transplant 2013;13:1400-4.
22. Mone T, Heldens J, Niemann CU. Deceased organ donor research: the last research frontier? Liver Transpl 2013;19:118-21.